PA
GWPH

PSI Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

PSI Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-400
Closed -$41K – 677
2019
Q4 		$41K Buy
+400
New +$44.9K 0.03% 283

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

PSI Advisors's GWPH Position: Q1 2020 in Review

PSI Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 400 shares — an estimated $41K sold.

PSI Advisors first reported a position in GWPH in Q4 2019 and held it in 1 quarter. The position peaked at $41K in Q4 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

  • PSI Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • PSI Advisors sold 400 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $41K.
  • PSI Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 1 quarter.
  • PSI Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $41K in Q4 2019.
  • 289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on PSI Advisors's 13F filing for Q1 2020, filed 15 May 2020.